Philadelphia-based Wistar Institute, a National Cancer Institute-designated basic laboratory cancer center, has named Ronny Drapkin, MD, PhD, its next president and CEO.
Dr. Drapkin will step into his leadership roles Nov. 30, according to an Oct. 6 Wistar Institute news release.
He succeeds Dario Altieri, MD, who has led the institute for a decade. Dr. Altieri will join Philadelphia-based Thomas Jefferson University’s Sidney Kimmel Medical College on Jan. 1, 2027, and serve as a special adviser to the director of Jefferson Health’s Sidney Kimmel Comprehensive Cancer Center.
Dr. Drapkin directs the Ovarian Cancer Research Center at Philadelphia-based Penn Medicine and co-directs the Ovarian Cancer Translational Center of Excellence at the Abramson Cancer Center.
He will oversee Wistar’s early-stage research in cancer, immunology and infectious disease, as well as its workforce training programs, the release said.
At the Becker's Perioperative Summit, taking place September 14–15 in Chicago, perioperative leaders and healthcare executives will focus on improving operating room efficiency, enhancing patient safety, optimizing staffing and driving innovation across surgical services. Apply for complimentary registration now.
